4th Quarter 2017 Update: Portfolio News and Activities
Happy new year!! We’re more than a week into 2018 and while this is typically a time to look ahead, we wanted to take a few minutes to highlight all the news from Q4 2017. We’ve said it before, but the Version One portfolio is filled with great startups doing incredible things. And as we […]
2017 Year in Review
This has been a critical year for us at Version One, as well as our ecosystem in general. The market frenzy surrounding crypto and blockchain challenges how VCs will evolve over the next years. In fact, the amount of money raised by startups via ICOs has surpassed early stage VC funding for internet companies. There is no […]
Our Approach to Investing in Genomics and Biosciences
It’s hard to believe that it has been a year and a half since we updated our healthcare thesis, as a follow-up to our blog series with Union Square Ventures on the future of healthcare. While we are still spending time on digital health, we have been focusing more on genomics and biosciences as a means to […]
Technology can boost efficiency, but that’s not always enough
We’ve been spending significant time on emerging tech lately. From the frenzy surrounding blockchain applications to the surge in medical research projects that are coming out of academia, it’s clear that disruption potential is high on the barometer right now. I’ve never felt more excited about our work as VCs than I do today. I […]
Our Core Beliefs
As a partnership evolves, you begin to formulate some basic rules and philosophies (whether formally or informally) to help guide long-term and short-term decision-making. It has been over four years since I’ve joined Version One, and just like any company, Boris and I need to continually take a step back and ask ourselves why we […]